C-PDRNãèãªãºã ããµããŒãïŒãã¥ã¢ã«ãšãã§ã¯ãã¢ã³ãã«ã¯ãC-PDRNãšã»ã©ããNPé åã§ããèã«ããªãšæœ€ããäžããŸãã ãšãã¿ã®ããçŸå®¹æ¶²ã§äŒžã³åºãããããã¯ã¹ãã£ãŒãªã®ã§ãäžžãå°ãŸã§ã ãš1ååãšããŠã¯å€ãããïŒ ä¹Ÿç¥ããããç§å¬ã«ã䜿ããããããªäœ¿çšæã ãªãšæããŸããð
ãã£ãšèŠãããããã¢ã€ãã REJURANÃçŸå®¹æ¶²
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬85äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
REJURAN ã¿ãŒã³ãªãŒããŒã¢ã³ãã« | 2,728å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬108äœ | èã®è¡šé¢ãã€ãããšããŠããŠå€æ¹ã®ããã¿ãæ°ã«ãªãã«ãããªããŸããïŒ | 詳现ãèŠã | |
REJURAN ã¢ã€ã¹ãã£ãŒããªãŒãã¡ã³ãã¢ã³ãã« | 3,850å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬122äœ | ãã£ã¡ããšããã¯ãªã¢ãªãã¯ã¹ãã£ã èãªãã¿ãããã£ãïŒïŒïŒïŒãã£ã±ãããšæããããã£ããä¿æ¹¿ | 詳现ãèŠã |
çŸå®¹æ¶²ã©ã³ãã³ã°
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
DECORTà ãªããœãŒã ã¢ããã³ã¹ãããªãã¢ã»ã©ã | 12,650å |
| ã¹ãã³ã±ã¢ã©ã³ãã³ã°ç¬¬2äœ | ããããªã£ãããŸã£ãèãæãããã»ãããŠããããããªã€ã¡ãŒãžã§ããïŒ | 詳现ãèŠã | |
SHISEIDO ã¢ã«ãã£ãã¥ãŒã³â¢ ãã¯ã©ã€ãžã³ã° ã»ã©ã | 9,900å(ç·šééšèª¿ã¹) |
| ã¹ã«ã¹ã«ã£ãšäŒžã³ãŠãèã«ãªãããšã»ãã®ããã€æãæããŸãã åŸèã¯ãããã | 詳现ãèŠã | ||
ã© ããã·ã¥ ã㌠ãšãã¡ã¯ã© ããŒã«ã±ã¢ ã»ã©ã | 5,280å |
| ã¹ãã³ã±ã¢ã©ã³ãã³ã°ç¬¬7äœ | ããããšãã¿ã®ãããã¯ã¹ãã£ãŒã§ã䌞ã³è銎æã¿å ±ã«âã¹ãšã€ããªããã©ãã£ãšãä¿æ¹¿ããŠãããŸãïŒ | 詳现ãèŠã | |
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬85äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
Torriden ãã€ãã€ã³ ã»ã©ã | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬72äœ | èã«ã®ãããšããã«ã¹ããšéŠŽæã¿ãŸãã銎æããšãã¿ã€ãããããµã©ãµã©ã«ãªãïŒ | 詳现ãèŠã | |
Anua ã¢ãŒã©ã€ã³é ž15 ã€ã³ãã³ã¹ã«ãŒãã³ã°ã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬89äœ | 軜ãããªãã¯ã¹ãã£ãŒã§çŽ æ©ãèã«éŠŽæã¿ã最ããããªäœ¿ãå¿å°ã§ãâš | 詳现ãèŠã | ||
numbuzin 5çª çœçã°ã«ã¿ããªã³ïŒ£çŸå®¹æ¶² | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬15äœ | ãšãã¿ã®ãããã¯ã¹ãã£ãŒãªã®ã«ããããããªãðð» | 詳现ãèŠã | |
Anua ããŒã¯ã¹ãããã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬32äœ | ä¿æ¹¿æåããã£ã·ããšé åãããŠããŠã ããäžæ¬ã§ããèããã£ãšããšããŸãâš | 詳现ãèŠã | ||
ã¢ãŒã¬ã¹ ããŒã¹ã ãã³ã㌠X | 7,150å(ç·šééšèª¿ã¹/ãªãŒãã³äŸ¡æ Œ) |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬17äœ | ãã¿ãã¿ãã«ããã èãªãã¿ãããã®ã§äœ¿ããããïŒãèã«ãã€ãã§ãã®ãå¬ããð | 詳现ãèŠã | |
manyo ã¬ã©ã¯ãã€ã¢ã·ã³2.0ãšãã»ã³ã¹ | 3,190å |
| ã¹ãã³ã±ã¢ã©ã³ãã³ã°ç¬¬62äœ | çŸå®¹æ¶²ã ãã©ãµã©ãµã©ããŠããŠããèã«éŠŽæãïŒ åŸã®ã¹ãã³ã±ã¢ã«é¿ããªããããã¿ã€ããªããŠè¯ã⪠| 詳现ãèŠã |
å¹åð* :ïŸããã®äººæ°ã¯ãã³ã
è²è£æ£ã¬ããÃãªãã¿ããŒãžã¥ æåã¯ã¬ãããçµæ§æ¿ãã®ã§ã³ã£ããããŸãããªãã¿ããŒãžã¥ãšéŠŽæãŸãããšãããã銎æã¿ãŸãïŒ ç§ã®ã¯ãã¯çµæ§åºç¯å²ã®ã¯ããªã®ã§ããã¬ããã§ããçšåºŠè£æ£ããããªãã¿ããŒãžã¥ã®æ¹ãå€ãã«å¡ã£ãŠãããŠéŠŽæãŸããŸããïŒ äžãããã¡ã³ããŒã·ã§ã³ã¯å¡ããŸãããããã§ã綺éºã«é ããŠãããŠããã¯ãã¹ã³ã¹çŽåŸã ãªããšâŠïŒïŒ ã©ããªäººã§ãè²ãåããããããšæããŸããïŒ çŸå®¹æ¶²æåãå ¥ã£ãŠããã®ã§ãã¯ã¹ãã£ãŒããã£ãšãã§ä¹Ÿç¥ããªãã£ãã®ã¯è¯ãã£ãã§ã*°â¡
ãã£ãšèŠã334
40
- 2022.12.20
ç§ã®ãå®ããªããð«°ð»ðâããâïžãâããâŸããâEléganceãªã¯ã€ããã«ãŒãžã¥ããžã¥ãŒ06BROWNâããâïžãâããâŸããâå æ¥æçš¿ãããŠé ããŸããïŒãšã¬ã¬ã³ã¹ã®ãªã¯ã€ããã«ãŒãžã¥ããžã¥ãŒã§ã*Â°â¡æ¯éåç»ã§ãã芧ãã ãããŸãð#å¬ã®èµ€...
ãã£ãšèŠã288
35
- 2023.01.04
Dior ãã£ãªãŒã« ããã¯ã¹ããŒãž ãã§ã€ã¹ ã°ã㊠ãã¬ãã å®äŸ¡5610å å ææçš¿ãããŠé ããŸãã Diorã®ããã¯ã¹ããŒãž ãã§ã€ã¹ ã°ã㊠ãã¬ããã§ã*°⡠ç¡å å·¥åç»ãªã®ã§è²å³ãªã©ããããããããšæããŸãïŒ ãã®ä»è©³ããããšã¯å æã®æçš¿ãã芧ãã ãããŸãð
ãã£ãšèŠã269
6
- 2023.03.11
ã·ããã£ãšããåã«ãªããð«°ð»ðâããâïžãâããâŸããâCandyDollã±ã¢ãªã€ã«ãã£ã³ããªãã501ãªãŒã«ããã³ã¯âããâïžãâããâŸããâå æ¥æçš¿ãããŠé ããŸããCandyDollã®ã±ã¢ãªã€ã«ãã£ã³ããªããã§ãð°è¶ãè²å³ãåç»ã®æ¹ãäŒã...
ãã£ãšèŠã260
20
- 2023.01.10
ã©ã¡ãè¶ çµ¶å¯æãéå®ãªããã¢ã³ã¹ã¿ãŒð«°ð»ðâããâïžãâããâŸããâKATEãªããã¢ã³ã¹ã¿ãŒEX-1çå€äžã®åç©«ç¥âããâïžãâããâŸããâå ææçš¿ãããŠé ããŸããKATEã®ãªããã¢ã³ã¹ã¿ãŒéå®EX-1çå€äžã®åç©«ç¥ã§ã*°â¡ç¡å å·¥åç»æ®ãçŽ...
ãã£ãšèŠã252
7
- 2023.02.26
SKINFOODã§æ°ã«ãªã£ãŠããã®è²·ã£ãŠã¿ã*°â¡ã¡ã¬å²è³Œå ¥åPart2ð«°ð»ðâããâïžãâããâŸããâSKINFOODããŒããã¹ã¯ãã¹ã4ç¹ã»ããã¹ããããªãŒã·ã¥ã¬ãŒããŒããã¹ã¯ã©ãã³ããŒããŒããã¹ã¯ã¬ã¢ã³ãã£ã«ãã¿ãŒããŒããã¹ã¯ãããŒã·ã¥...
ãã£ãšèŠã246
18
- 2023.04.03
åå詳现æ å ±REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã«
- ãã©ã³ãå
- REJURAN(ãªãžã¥ã©ã³)
- ã©ã³ãã³ã°IN
- å šäœã©ã³ãã³ã°å¹Žä»£å¥ã©ã³ãã³ã°è質å¥ã©ã³ãã³ã°
- 容éã»åèäŸ¡æ Œ
- 30ml: 8,250å
- åå説æ
- ãªãžã¥ã©ã³ã®ãªãªãžãã«PDRNãå ¥ã£ãŠããããªãã€çŸå®¹æ¶²ã c-PDRNâ»1 ããã€ã¢ã·ã³ã¢ããâ»2ããã¢ã«ãã³é žïŒ®ïœâ»2 ãã«ã³ãŸãŠæ ¹ãšãã¹â»3ãé åã è§è³ªå±€ãŸã§æœ€ããäžããèãªãºã ãæŽããâ»4ããšã§åŒŸåã®ããèæ¬æ¥ã®çŸãããžã ãªãžã¥ã©ã³æé«æè¡ã¹ããŒãšã€ãžã³ã°â»5äžèœçŸå®¹æ¶²ã â»1ãå æ°Žå解 : æŽèæå â»2ãé åç®çïŒä¿æ¹¿ â»3ãé åç®ç: æŽèæå â»4ãèããããã£ãŠããããããªç¶æ ã®ããš â»5ã幎霢ã«åãããã±ã¢ã®ããš
- ã¡ãŒã«ãŒå
- Pharma Research
- ã«ããŽãª
- ã¹ãã³ã±ã¢ã»åºç€åç²§å > çŸå®¹æ¶²
ã³ã¡ã³ã